Relay Therapeutics, Inc. RLAY Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Relay Therapeutics, Inc. (RLAY) reported comprehensive income (loss), net of tax, attributable to parent of -$73.46M in Q1 2026.
- How has Relay Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Relay Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent increased by 3.4% year-over-year, from -$76.04M to -$73.46M.
- What is the long-term trend for Relay Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a -6.9% compound annual growth rate (CAGR), from -$365.02M to -$274.76M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from all sources, combining net income with other comprehensive income items. It provides a comprehensive view of the company's total financial performance and the impact of non-operating factors on shareholder equity. Investors use this to understand the full scope of value creation or erosion beyond the standard net income figure.